Clinical and Experimental Nephrology

, Volume 1, Issue 3, pp 179–186 | Cite as

Growth hormone resistance in uremia

  • Satoshi Hisano
  • Winnie Chan
  • Kay Latta
  • Richard J KriegJr.
  • James CM Chan
Review Article
First Online:
Received:
Revised:
Accepted:
  • 30 Downloads

Abstract

Growth retardation is a major complication in children with uremia. Protein restriction, calorie deficit, metabolic acidosis, renal osteodystrophy, and endocrinologic disturbances contribute to the growth failure. The effect of these factors on growth retardation can be attenuated in part by therapy with vitamin D metabolites, adequate nutrition, alkalization, and dialysis. Linear growth in children with uremia is markedly retarded despite normal or increased levels of circulating serum growth hormone. An increased growth hormone level in children with uremia is due to normal growth hormone secretion from the pituitary gland and impaired growth hormone clearance in the kidney. However, the elevated growth hormone level does not lead to a commensurate rise in serum insulin-like growth factor I (IGF-I); the serum IGF-I level is decreased or normal in relation to the degree of renal failure. This discrepancy suggests growth hormone resistance in the liver in uremia. Recent molecular techniques open a new era in studying the gene expression for growth hormone or IGF-I. There is no doubt today that growth hormone treatment has the beneficial effect of growth promotion in children with uremia, which also suggests endogenous growth hormone resistance in target organs or target cells in uremia.

Key words

uremia growth failure growth hormone growth hormone resistance insulin-like growth factor I growth hormone receptor mRNA 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Tönshoff B, Schafer F, Mehls O. Disturbance of growth hormone-insulin-like growth factor axis in uremia. Pediatr Nephrol 1990;4:654–662.CrossRefPubMedGoogle Scholar
  2. 2.
    Johnson J, Maack T. Renal extraction, filtration, absorption and catabolism of growth hormone. Am J Physiol 1977;223:F185-F189.Google Scholar
  3. 3.
    Tönshoff B, Mehls O, Heinrich U, Blum WF, Ranke MB, Schauer A. Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease. J Pediatr 1990;116:561–566.CrossRefPubMedGoogle Scholar
  4. 4.
    Tönshoff B, Tönshoff C, Mehls O, Pinkowski J, Blum WF, Heinrick V, Stover B, Gretz N, Grwoth chronic renal failure: no adverse effect on glomerular filtration rate. Eur J Pediatr 1992;151:601–607.CrossRefPubMedGoogle Scholar
  5. 5.
    Fine RN, Kohaut EC, Brown D, Perlman AJ, for the Genentech Cooperative Study Group. Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. J Pediatr 1994;124:374–382.CrossRefPubMedGoogle Scholar
  6. 6.
    Fine RN, Attie KM, Kuntze J, Brown DF, Kohout EC. Recombinant human growth hormone in infants and young children with chronic insufficiency. Pediatr Nephrol 1995;9:451–457.CrossRefPubMedGoogle Scholar
  7. 7.
    Fine RN. Recombinant human growth hormone in children with chronic renal insufficiency—clinical update; 1995. Kidney Int 1996;49 (suppl):s115-s118.Google Scholar
  8. 8.
    Mehls O, Ritz E, Hunziker EB, Eggli P, Heinrich U, Zapf J. Improvement of growth and food utilization by human recombinant growth hormone in uremia. Kidney Int 1988:33:45–52.CrossRefPubMedGoogle Scholar
  9. 9.
    Powell DR, Rosenfeld RG, Hintz RI. Effects of growth hormone therapy and malnutrition on the growth of rats with renal failure. Pediatr Nephrol 1988;2:425–430.CrossRefPubMedGoogle Scholar
  10. 10.
    Kainer G, Nakano M, Massie FS Jr, Foreman JW, Chan JCM. Hypercalciuria due to combined growth hormone and calcitriol therapy in uremia: effects of growth hormone on mineral homeostasis in 75% nephrectomized weanling rats. Pediatr Res 1991;30:528–533.CrossRefPubMedGoogle Scholar
  11. 11.
    Salmon WD, Dau WH. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 1957;49:825–836.PubMedGoogle Scholar
  12. 12.
    D'Ercole AJ, Stiles AD, Underwood LE. Tissue concentrations of somatomedin C further evidence for multiple sites of synthesis and paracrine or autocrine mechanism of action. Proc Natl Acad Sci USA 1984;81:935–939.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Krieg RJ Jr, Santos F, Chan JCM. Growth hormone, insulin-like growth factor and the kidney. Kidney Int 1995;48:321–336.CrossRefPubMedGoogle Scholar
  14. 14.
    Schwalbe SL, Betts PR, Rayner PH, Rudd BT. Somatomedin in growth disorders and chronic renal insufficiency in children. Br Med J 1977;1:679–682.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Phillips LS, Pennisi AJ, Belosky DC, Uittenbogaart C, Ettenger RB, Malekzadeh MH, Fine RN. Somatomedin activity and inorganic sulfate in children undergoing hemodialysis. J Clin Endocrinol Metab 1978;46:165–168.CrossRefPubMedGoogle Scholar
  16. 16.
    Blum WF, Ranke MB, Kietzmann K, Tönshoff B, Mehls O. Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uremia. Pediatr Nephrol 1991;5:539–544.CrossRefPubMedGoogle Scholar
  17. 17.
    Lowe WL Jr, Lasky SR, LeRoith D, Roberts CT Jr. Distribution and regulation of rat insulin-like growth factor I meassenger ribonucleic acids encoding alternative carboxylterminal E-peptides: evidence for differential processing and regulation in liver. Mol Endocrinol 1988;2:528–535.CrossRefPubMedGoogle Scholar
  18. 18.
    Mathews LS, Hammer RE, Behringer RR, D'Ercole AJ, Bell GI, Brinster RL, Palmiter RD. Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology 1988;123:2827–2833.CrossRefPubMedGoogle Scholar
  19. 19.
    Chan W, Valerie KC, Chan JCM. Expression of insulin-like growth factor-I in uremic rats: growth hormone resistance and nutritional intake. Kidney Int 1993; 43:790–795.CrossRefPubMedGoogle Scholar
  20. 20.
    Tönshoff B, Edén S, Weiser E, Carlsson B, Robinson ICAF, Blum WF, Mehls O. Reduced hepatic growth hormone (GH) receptor gene expression and increased plasma GH binding protein in experimental uremia. Kidney Int. 1994;45:1085–1092.CrossRefPubMedGoogle Scholar
  21. 21.
    Hisano S, Chan W, Latta K, Krieg RJ Jr., Chan, JCM, Uremia results in impaired induction of liver IGF-I mRNA and GH receptor mRNA even after long-term rhGH treatment. J Am Soc Nephrol 1996;7:1855 (abstr).Google Scholar
  22. 22.
    Haffner D, Schaefer F, Girad J, Ritz E, Mehlns O. Metabolic clearance of recombinant human growth hormone in health and chronic failure. J Clin Invest 1994; 93:1163–1171.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Tönshoff B, Veldhuis JD, Heinrich VU, Mehls O. Deconvolution analysis of spontaneous nocturnal growth hormone secretion in prepubertal children with preterminal chronic renal failure and with end-stage renal disease. Pediatr Res 1995;37:86–93.CrossRefPubMedGoogle Scholar
  24. 24.
    Schaefer F, Veldhuis JD, Stanhope R, Jones J, Scharer K, Cooperative Study Group on Pubertal Development in Chronic Renal Failure. Alterations in growth hormone secretion and clearance in peripubertal boys with chronic renal failure and after renal transplantation. J Clin Endocrinol Metab 1994;78:1298–1306.PubMedGoogle Scholar
  25. 25.
    Tönshoff B, Blum WF, Mehls O. Serum insulin-like growth factors and their binding proteins in children with end-stage renal failure. Pediatr Nephrol 1996;10:269–274CrossRefPubMedGoogle Scholar
  26. 26.
    Tönshoff B, Blum WF, Mehls O. Derangements of the somatotropic hormone axis in chronic renal failure. Kidney Int 1997;51(suppl 58):S106-S113.Google Scholar
  27. 27.
    Hanna JD, Santos F, Foreman JW, Chan JCM, Han VKM. Insulin-like growth factor-I gene expression in the tibial epiphyseal growth plate of growth hormone-treated uremic rats. Kidney Int 1995;47:1374–1382.CrossRefPubMedGoogle Scholar
  28. 28.
    Hanna JD, Krieg RJ Jr, Scheinman JI, Chan JCM. Effects of uremia on growth in children. Semin Nephrol 1996;16:230–241.PubMedGoogle Scholar
  29. 29.
    Isgaard J, Carlson L, Isaksson OGP, Jansson JO. Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger RNA in skeletal tissues more effectively than continuous GH infusion. Endocrinology 1988;123:2605–2610.CrossRefPubMedGoogle Scholar
  30. 30.
    Barash I, Madar Z, Gertler A. Down-regulation of prolaction receptors in the liver, mammary gland and kidney of female virgin rat, infused with ovine prolactin or human growth hormone. Biochem Biophys Res Commun 1983;116:644–650.CrossRefPubMedGoogle Scholar
  31. 31.
    Santos F, Chan JCM, Krieg RJ, Niimi K, Hanna JD, Wellons MD, Poletti LF. Growth hormone secretion from pituitary cells in chronic renal insufficiency. Kidney Int 1992;41:356–360.CrossRefPubMedGoogle Scholar
  32. 32.
    Krieg RJ Jr, Latta K, Niimi K, Chan JCM, Veldhuis JD. Impact of uremia on food efficiency and the pulsatile mode of growth hormone secretion in rats. J Endocrinol 1995;146:509–517.CrossRefPubMedGoogle Scholar
  33. 33.
    Krieg RJ Jr, Chan W, Matt DW, Chan JCM. Growth hormone (GH) and insulin-like growth factor-I receptor (IGF-IR) mRNA in rat pituitary under conditions of chronic uremia. Pediatr Res 1992;31:336A (abstr).Google Scholar
  34. 34.
    Metzger DL. Kerrigan JR, Krieg RJ Jr, Chan JCM, Rogol AD. Alterations in the neuroendocrine control of growth hormone secretion in the rat. Kidney Int 1993;43:1042–1048.CrossRefPubMedGoogle Scholar
  35. 35.
    Baumann G. Growth hormone binding protein and free growth hormone in chronic renal failure. Pediatr Nephrol 1996;10:328–330.CrossRefPubMedGoogle Scholar
  36. 36.
    Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood WI. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 1987;330:537–543.CrossRefPubMedGoogle Scholar
  37. 37.
    Baumann G, Shaw MA, Amburn K. Circulating growth hormone binding proteins. J Endocrinol Invest 1994;17:67–81.CrossRefPubMedGoogle Scholar
  38. 38.
    Baumann G. Growth hormone binding protein: state of the art. J. Endocrinol 1994;141:1–6.CrossRefPubMedGoogle Scholar
  39. 39.
    Postel-Vinay MC, Tar A, Crosnier H, Broyer M, Rappaport R, Tönshoff B, Mehls O. Plasma growth hormone-binding activity is low in uremic children. Pediatr Nephrol 1991;5:545–547.CrossRefPubMedGoogle Scholar
  40. 40.
    Maheshwari HG, Rifkin I, Butler J, Norman M. Growth hormone binding protein in patients with renal failure. Acta Endocrinol 1992;127:485–488.PubMedGoogle Scholar
  41. 41.
    Rees L, Maxwell H. The hypothalamo-pituitary-growth hormone insulin-like growth factor I axis in children with chronic renal failure. Kidney Int 1996;49: (suppl):S109-S114.Google Scholar
  42. 42.
    Smith WC, Talamantes F. Gestational profile and affinity cross-linking of the mouse serum growth hormone-binding protein. Endocrinology 1988;123:1489–1494.CrossRefPubMedGoogle Scholar
  43. 43.
    Haldosen LA, Gustafsson JA. Detection of glycosylated growth hormone-binding proteins in rat serum. Mol Cell Endocrinol 1990;68:187–194.CrossRefPubMedGoogle Scholar
  44. 44.
    Maiter D, Walker JL, Adam E, Moats-Staats B, Mulumba N, Ketelslegers J-M, Underwood LE. Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver. Endocrinology 1992;130:3257–3264.CrossRefPubMedGoogle Scholar
  45. 45.
    Mullis PE, Lund T, Patel MS, Brook CGD, Brickell PM. Regulation of human growth hormone in a human hepatoma cell line. Mol Cell Endocrinol 1991;76:125–133.CrossRefPubMedGoogle Scholar
  46. 46.
    Fukuda N, Tanaka H, Tominaga Y, Fukagawa M, Kurokawa K, Seino Y. Decreased 1,25-dihydroxyvitamin, D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 1993;92:1436–1443.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Duqesnov P, Sobrier ML, Amselem S, Goossens M. Defective membrane expression of human growth hormone (GH) receptor causes Laron-type GH insensitivity syndrome. Proc Natl Acad Sci USA 1991;88:10272–10276.CrossRefGoogle Scholar
  48. 48.
    Isaksson OGP, Nilsson A, Isgaard J, Lindahl A. Cartilage as a target tissue for growth hormone and insulin-like growth factor I. Acta Paediatr Scand 1990; 367(suppl):137–141.CrossRefGoogle Scholar
  49. 49.
    Kurose H, Yamaoka K, Okada S, Nakajima S, Seino Y. 1,25 dihydroxyvitamin D3 increases insulin-like growth factor (IGF-I) receptors in clonal osteoblastic cells. Study on interaction of IGF-I and 1,25-(OH)2D3. Endocrinology 1990;126:2088–2094.CrossRefPubMedGoogle Scholar
  50. 50.
    Linkhart TA, Mohan S. Parathyroid hormone stimulates release of insulin-like growth factor-I (IGF-I) and IGF-II from neonatal mouse in organ culture. Endocrinology 1989;125:1484–1491.CrossRefPubMedGoogle Scholar
  51. 51.
    Kanzaki S, Hosoda K, Moriwake T, Tanaka H, Kubo T, Inoue M, Higuchi J, Yamaji T, Seino Y. Serum propeptide and intact molecular osteocalcin in normal children and children with growth hormone (GH) deficiency: a potential marker of bone growth and response to GH therapy. J Clin Endocrinol Metab 1992;75:1104–1109.PubMedGoogle Scholar
  52. 52.
    Fujimoto S, Kubo T, Tanaka H, Miura M, Seino S. Urinary pyridinoline and deoxypyridinoline in healthy children and in children with growth hormone deficiency. J Clin Endocrinol Metab 1995;80:1022–1928.Google Scholar
  53. 53.
    Salusky IB, Goodman WG. Growth hormone and calcitriol as modifiers of formation in renal osteodystrophy. Kidney Int 1995;48:657–665.CrossRefPubMedGoogle Scholar
  54. 54.
    Hisano S, Langman CB, Latta K, Krieg RJ Jr, Chan JCM. Vitamin D metabolites and growth hormone therapy in uremic rats: the short-term effect on growth failure and hyperparathyroidism. Nephrology 1996; 2:247–252.CrossRefGoogle Scholar
  55. 55.
    Nilsson A, Lindahl A, Eden S, Isaksson OGP. Demonstration of growth hormone receptors in cultured rat epiphyseal chondrocytes by specific binding of growth hormone and immunohistochemistry. J Endocrinol 1989;122:69–77.CrossRefPubMedGoogle Scholar
  56. 56.
    Nilsson A, Carlsson B, Mathews L, Isaksson OGP. Growth hormone regulation of the growth hormone receptor mRNA in cultured rat epiphysealchondrocytes. Mol Cell Endocrinol 1990;70:237–246.CrossRefPubMedGoogle Scholar
  57. 57.
    Isaksson OGP, Lindahl A, Nilsson A, Isgaard J. Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 1987;9:426–438.CrossRefGoogle Scholar
  58. 58.
    Hunziker EB, Wagner J, Zaph J. Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vitro. J Clin Invest 1994;93:1078–1086.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Dau WH, Rotwein P. Insulin-like growth factors I and II. Peptide, meassenger ribonucleic acid and gene structures, serum, and tissue concentations. Endocr Rev 1989;10:68–91.CrossRefGoogle Scholar

Copyright information

© CEN/CLJ 1997

Authors and Affiliations

  • Satoshi Hisano
    • 1
  • Winnie Chan
    • 1
  • Kay Latta
    • 1
  • Richard J KriegJr.
    • 2
  • James CM Chan
    • 1
  1. 1.Department of PediatricsVirginia Commonwealth University, Medical College of VirginiaRichmondUSA
  2. 2.Department of AnatomyVirginia Commonwealth University, Medical College of VirginiaRichmondUSA

Personalised recommendations